Bausch Health Companies Inc.
Bausch Health Companies Inc. (formerly known as Valeant Pharmaceuticals) is a multinational specialty pharmaceutical company with headquarters in Canada. Bausch Health Companies Inc. produces, manufactures, and markets a wide range of pharmaceutical products predominantly aimed at dermatology, gastrointestinal disorders, eye health, neurology, and branded generics. Bausch & Lomb, one of the world's largest suppliers of eye health products and is owned by Valeant Pharmaceuticals.
Valeant pharmaceuticals originated in 1959 as ICN Pharmaceuticals and has grown rapidly through a series of mergers and acquisitions. The company's largest acquisitions were Bausch & Lomb in 2013 and Salix Pharmaceuticals in 2015.
Bausch Health Companies Inc. trades on the New York Stock Exchange (NYSE) under the ticker symbol "BHC".
Bausch Health Companies Inc. Market Influences
Among the wide range of factors that influence Bausch Health Companies Inc., shares are affected by a range of different factors. These influences include governmental policy relating to the development and commercialisation of pharmaceuticals, economic policy and the general economic outlook, market sentiment and the industry’s performance and internal developments within Bausch Health Companies Inc..